Alexandrium spp.: From Toxicity to Potential Biotechnological Benefits

Mar Drugs. 2023 Dec 30;22(1):31. doi: 10.3390/md22010031.

Abstract

Many dinoflagellates of the genus Alexandrium are well known for being responsible for harmful algal blooms (HABs), producing potent toxins that cause damages to other marine organisms, aquaculture, fishery, tourism, as well as induce human intoxications and even death after consumption of contaminated shellfish or fish. In this review, we summarize potential bioprospecting associated to the genus Alexandrium, including which Alexandrium spp. produce metabolites with anticancer, antimicrobial, antiviral, as well as anti-Alzheimer applications. When available, we report their mechanisms of action and targets. We also discuss recent progress on the identification of secondary metabolites with biological properties favorable to human health and aquaculture. Altogether, this information highlights the importance of studying which culturing conditions induce the activation of enzymatic pathways responsible for the synthesis of bioactive metabolites. It also suggests considering and comparing clones collected in different locations for toxin monitoring and marine bioprospecting. This review can be of interest not only for the scientific community, but also for the entire population and industries.

Keywords: Alexandrium spp.; anticancer; biotechnological applications; harmful algal blooms; toxins.

Publication types

  • Review

MeSH terms

  • Animals
  • Aquaculture
  • Bioprospecting
  • Biotechnology
  • Dinoflagellida*
  • Harmful Algal Bloom
  • Humans

Grants and funding

This research received no external funding.